Hydrocodone moved to Schedule II in DEA final rule

Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.

With the issuance of this final rule, the Administrator of the Drug Enforcement Administration reschedules hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. This act...

Key changes to the Stark II final rule.

Medicare program; revisions to payment policies under the physician fee schedule, clinical laboratory fee schedule & other revisions to Part B for CY 2014. Final rule with comment period.

This major final rule with comment period addresses changes to the physician fee schedule, clinical laboratory fee schedule, and other Medicare Part B payment policies to ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services. This final rule with comment period also includes a discussion in the Supplementary Information regarding v...

Afterword: The final ACO rule.

Forecasting Final Schedule and Cost of Projects by Using Statistical and Mathematical Method

Earned value management (EVM) has prepared some methods to forecast final costs of projects. These methods were not developed since the start of formation and were gradually completed, of course with one exception that is its authenticity, they are still remained unchanged. At the present time EVM guide does not apply from schedule indices to forecast schedule for completion of project and ...